C-reactive protein to rule out complicated pneumococcal disease manifestations: a retrospective cohort study in adults with pneumococcal bacteraemia

C-reactive protein to rule out complicated pneumococcal disease manifestations: a retrospective cohort study in adults with pneumococcal bacteraemia

Objectives: To explore the negative predictive value (NPV) of C-reactive protein (CRP) at admission to exclude complicated disease manifestations of pneumococcal disease.Methods: A Dutch multicentre retrospective cohort study was conducted between 01-01-2012 and 30-06-2020. Adults with positive bloo...

Full description

Bibliographic Details
Main Authors:	Milou J.V. Serbée, Elisabeth A. Dulfer, Kirsten K.T. Dirkx, Ron Bosboom, Bas Robberts, Heiman F.L. Wertheim, Bert Mulder, Marien I. de Jonge, Carel F. Schaars, Caroline M.A. Swanink, Amelieke J.H. Cremers
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	International Journal of Infectious Diseases
Subjects:	Streptococcus pneumoniae C-reactive protein Invasive pneumococcal disease Empyema
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971221006433

Similar Items

Ventricular empyema presenting as a complication of pneumococcal meningitis in a toddler
by: Parthasarathi Muthusamy, et al.
Published: (2023-01-01)

The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
by: Kirsten K.T. Dirkx, et al.
Published: (2021-10-01)

Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan
by: Jun Yi Sim, et al.
Published: (2020-11-01)

Differential Pneumococcal Growth Features in Severe Invasive Disease Manifestations
by: Daan W. Arends, et al.
Published: (2022-06-01)

A false‐positive pneumococcal rapid urinary antigen test in Streptococcus intermedius infection
by: Saeko Takahashi, et al.
Published: (2019-10-01)

Outcome of Severe Bacterial Pneumonia in the Era of Pneumococcal Vaccination
by: Teresa del Rosal, et al.
Published: (2020-12-01)

Recurrent pneumococcal bacteraemia in a patient with systemic lupus erythematosus
by: Simon M. Durkin, et al.
Published: (2021-01-01)

Intrafamilial Transmission of Pneumococcal Acute Spontaneous Peritonitis
by: Ioanna Papadatou, et al.
Published: (2023-05-01)

Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine
by: Murat Sütçü, et al.
Published: (2017-02-01)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2021-10-01)

Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children
by: Leigh M. Howard, et al.
Published: (2023-09-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
by: Cornelis H. van Werkhoven
Published: (2017-05-01)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
by: Nobuhiro Asai, et al.
Published: (2021-11-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

Pneumococcal disease in Thailand
by: Amgad Gamil, et al.
Published: (2021-01-01)

Recent progress in pneumococcal protein vaccines
by: Sha Li, et al.
Published: (2023-09-01)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
by: Hyunju Lee, et al.
Published: (2014-02-01)

Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment
by: Choon How How, et al.
Published: (2016-09-01)

Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
by: Stephanie Perniciaro, et al.
Published: (2021-08-01)

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015
by: Catarina Silva-Costa, et al.
Published: (2018-07-01)

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
by: Juan Buades, et al.
Published: (2021-01-01)

Pneumococcal Serogroups Causing the Most of the Invasive Diseases in Kayseri
by: Duygu EŞEL, et al.
Published: (2002-03-01)

Burden of Hospitalizations Related to Pneumococcal Infection in Spain (2016–2020)
by: Ruth Gil-Prieto, et al.
Published: (2023-01-01)

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
by: Salini Mohanty, et al.
Published: (2023-01-01)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
by: Anna M.M. van Deursen, et al.
Published: (2012-11-01)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
by: Sara Tomczyk, et al.
Published: (2018-04-01)

Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine
by: Antoni Payeras, et al.
Published: (2015-04-01)

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
by: Maria Deloria Knoll, et al.
Published: (2021-04-01)

Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq
by: Al-Jumaili A, et al.
Published: (2023-05-01)

A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
by: Jacob Dag Berild, et al.
Published: (2020-04-01)

Modern approaches to the prevention of pneumococcal infection
by: S. M. Kharit, et al.
Published: (2015-12-01)

Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trialResearch in context
by: Heidi Smith-Vaughan, et al.
Published: (2023-03-01)

Chronic medical conditions associated with invasive pneumococcal diseases in inpatients in teaching hospitals in São Paulo city: Estimating antimicrobial susceptibility and serotype-coverage of pneumococcal vaccines
by: Renato A. Kfouri, et al.
Published: (2023-03-01)

Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2024-02-01)

Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan
by: Ching-Fen Shen, et al.
Published: (2013-09-01)

Pediatric Pneumococcal Serotypes in 4 European Countries
by: Germaine Hanquet, et al.
Published: (2010-09-01)

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
by: Yadong A. Cui, et al.
Published: (2017-06-01)

Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden
by: Karin Bergman, et al.
Published: (2021-08-01)